These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33277949)

  • 1. Insulin binding to the analytical antibody sandwich pair OXI-005 and HUI-018: Epitope mapping and binding properties.
    Johansson E; Wu X; Yu B; Yang Z; Cao Z; Wiberg C; Jeppesen CB; Poulsen F
    Protein Sci; 2021 Feb; 30(2):485-496. PubMed ID: 33277949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Analysis of Der p 1-Antibody Complexes and Comparison with Complexes of Proteins or Peptides with Monoclonal Antibodies.
    Osinski T; Pomés A; Majorek KA; Glesner J; Offermann LR; Vailes LD; Chapman MD; Minor W; Chruszcz M
    J Immunol; 2015 Jul; 195(1):307-16. PubMed ID: 26026055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
    Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
    Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8.
    Malia TJ; Teplyakov A; Ernst R; Wu SJ; Lacy ER; Liu X; Vandermeeren M; Mercken M; Luo J; Sweet RW; Gilliland GL
    Proteins; 2016 Apr; 84(4):427-34. PubMed ID: 26800003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of an anti-interleukin-2 monoclonal antibody Fab complexed with an antigenic nonapeptide.
    Afonin PV; Fokin AV; Tsygannik IN; Mikhailova IY; Onoprienko LV; Mikhaleva II; Ivanov VT; Mareeva TY; Nesmeyanov VA; Li N; Pangborn WA; Duax WL; Pletnev VZ
    Protein Sci; 2001 Aug; 10(8):1514-21. PubMed ID: 11468348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations.
    Král V; Mader P; Collard R; Fábry M; Horejsí M; Rezácová P; Kozísek M; Závada J; Sedlácek J; Rulísek L; Brynda J
    Proteins; 2008 May; 71(3):1275-87. PubMed ID: 18041760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.
    Acharya P; Tolbert WD; Gohain N; Wu X; Yu L; Liu T; Huang W; Huang CC; Kwon YD; Louder RK; Luongo TS; McLellan JS; Pancera M; Yang Y; Zhang B; Flinko R; Foulke JS; Sajadi MM; Kamin-Lewis R; Robinson JE; Martin L; Kwong PD; Guan Y; DeVico AL; Lewis GK; Pazgier M
    J Virol; 2014 Nov; 88(21):12895-906. PubMed ID: 25165110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24.
    Monaco-Malbet S; Berthet-Colominas C; Novelli A; Battaï N; Piga N; Cheynet V; Mallet F; Cusack S
    Structure; 2000 Oct; 8(10):1069-77. PubMed ID: 11080628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of protein antigens with antibodies.
    Davies DR; Cohen GH
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):7-12. PubMed ID: 8552677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
    Tulip WR; Varghese JN; Laver WG; Webster RG; Colman PM
    J Mol Biol; 1992 Sep; 227(1):122-48. PubMed ID: 1381757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving toward generalizable NZ-1 labeling for 3D structure determination with optimized epitope-tag insertion.
    Tamura-Sakaguchi R; Aruga R; Hirose M; Ekimoto T; Miyake T; Hizukuri Y; Oi R; Kaneko MK; Kato Y; Akiyama Y; Ikeguchi M; Iwasaki K; Nogi T
    Acta Crystallogr D Struct Biol; 2021 May; 77(Pt 5):645-662. PubMed ID: 33950020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.
    Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM
    Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β.
    Blech M; Peter D; Fischer P; Bauer MM; Hafner M; Zeeb M; Nar H
    J Mol Biol; 2013 Jan; 425(1):94-111. PubMed ID: 23041424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
    Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
    Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the binding constants for three HPr-specific monoclonal antibodies and their Fab fragments.
    Smallshaw JE; Brokx S; Lee JS; Waygood EB
    J Mol Biol; 1998 Jul; 280(5):765-74. PubMed ID: 9671548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.